China's export restrictions on research monkeys, implemented in 2020 due to COVID-19, have significantly impacted US biotech and vaccine development. These primates, particularly macaques, are still considered indispensable for certain research, especially for vaccines and gene therapies, due to their physiological similarities to humans. While alternative testing methods are advancing, the demand for monkeys for complex biological studies remains high, leading to substantial price increases and project delays for US researchers. AI
IMPACT Disruptions in primate supply chains could slow the development and testing of novel biological therapies and vaccines.
RANK_REASON Significant disruption to a critical supply chain for biotech research due to policy changes. [lever_c_demoted from significant: ic=1 ai=0.7]
- China
- ChinaTalk
- COVID-19
- FDA Modernization Act 2.0
- Macaca
- National Academies Press
- rhesus macaque
- United States Food and Drug Administration
- United States National Institutes of Health
- Vox
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
